Assessing the presence of oligoclonal IgM bands as a prognostic biomarker of cognitive decline in the early stages of multiple sclerosis

ConclusionThere are no remarkable cognitive differences between LS-OCMB – and LS-OCMB+ patients in the early stages of MS.

Source: Brain and Behavior - November 19, 2021 Category: Neurology Authors: Cl àudia Coll‐Martinez, Ester Quintana, Judit Salavedra‐Pont, Maria Buxó, Marina González‐del‐Rio, Immaculada Gómez, María Muñoz‐San Martín, Luisa María Villar, Gary Álvarez‐Bravo, René Robles‐Cedeño, Lluís Ramió‐Tor Tags: ORIGINAL ARTICLE Source Type: research